美國UBI集團暨聯生藥與聯亞藥董事長王長怡博士 受邀在2018揚州生物醫藥論壇中專題演講

美國UBI集團暨聯生藥(6471)與聯亞藥(6562)董事長王長怡博士受邀於25日在揚州月畔灣酒店由揚州國家高新技術產業開發區舉辦的「2018揚州生物醫藥論壇」中給予專題演講。

王長怡董事長以「揚州古名城: 21世紀新藥生產重鎮,美台UBI集團領銜起跑」為題闡述UBI集團選擇在中國文化古城揚州落地發展蛋白質/單株抗體藥物的規劃與願景。本大會出席講者還包含中國著名專家學者陳志南 (中國工程院院士)、王廣基 (中國工程院院士)、朱鳳昌 (中國藥學會技術部專家)與政府機構官員王敦嵐 (江蘇省食品藥物監督管理局處長),同時也邀美國國家衛生研究院 (NIH) 國家過敏和傳染病研究所(NIAID)愛滋病免疫病毒學實驗室主任的Dr. Chun Tae-Wook、哈佛醫學院醫學副教授暨波士頓布裡格姆婦女醫院(BWH)和麻省總醫院(MGH)的傳染病專科醫生的Dr. Mathias D. Lichterfeld,以及GE醫療公司生物藥品製造解決方案事業部的總經理Brian Taylor於大會中給予專題演講。

繼續閱讀

發表於 公司新聞, 生醫新知, 產業訊息, 社會經濟 | 發表迴響

以色列榮登全球第八名長壽國家 民眾講究飲食"禁忌多"【消失的國界】

發表於 社會經濟 | 發表迴響

《老謝看世界》2018.04.21 中美科技戰開打!面對貿易保護 央行該出手了?-來賓 林錫銘

發表於 政治觀察, 社會經濟 | 發表迴響

PLANNING WITHOUT GOD


Confusion and conflict versus provision and protection—which would you prefer? When we leave God out of our plans, we’re inviting all sorts of chaos into our lives, not to mention regret and loss. In this message, Dr. Stanley warns us against going our own way without a thought to what God thinks about our choices. God’s plans are the best plans, so why not partner with Him?

發表於 歷史軼聞, 社會經濟 | 發表迴響

聖經鳥瞰10 約書亞記,士師記與路徳記 (王生台弟兄)

發表於 歷史軼聞 | 發表迴響

數字台灣HD202加密貨幣浪潮 謝金河 廖世偉 劉世偉

發表於 政治觀察, 社會經濟 | 發表迴響

《文茜世界周報》荷蘭老人最無憂 長照政策領先全球

發表於 政治觀察, 社會經濟 | 發表迴響

《老謝看世界》2018.04.13 高資產財富報告 「保值、增值、傳承」揭開財富密碼 – 來賓 李玉秋

發表於 政治觀察, 社會經濟 | 發表迴響

NOAH – BLAMELESS SERVANT OF GOD​


How do you obey when you don’t have the full picture? Learn from Noah. In this message, Dr. Stanley teaches us that, like Noah, we all have divine assignments. No matter what God calls us to do, our responsibility is to obey His instructions and trust Him to guide us. Discover the freedom in relying on God’s plan and not your own.

發表於 歷史軼聞, 社會經濟 | 發表迴響

聖經鳥瞰9 申命記(王生台弟兄)

發表於 歷史軼聞 | 發表迴響

數字台灣HD201直擊西班牙MWC 看5G發展新應用 謝金河 鄭清文 林宏達

發表於 政治觀察, 社會經濟 | 發表迴響

舌尖上的印度! 洋蔥用得比香料還多【消失的國界】

發表於 社會經濟 | 發表迴響

United Neuroscience and University of Texas Southwestern Medical Center Announce Collaboration to Evaluate Endobody Vaccine Candidates Directed at Tau Protein for the Treatment and Prevention of Alzheimer’s Disease

Candidates Generated with United Neuroscience Endobody Technology Will be Tested at the Center for Alzheimer’s and Neurodegenerative Diseases

DUBLIN, April 11, 2018 /PRNewswire/ — United Neuroscience, Ltd., (UNS), today announced that it has signed a collaboration agreement with the Center for Alzheimer’s and Neurodegenerative Diseases at the University of Texas Southwestern Medical Center to identify distinct pathogenic species of tau protein and evaluate promising therapeutic vaccine candidates to contribute to therapies for Alzheimer’s and other neurodegenerative diseases. As part of the collaboration, the Center for Alzheimer’s and Neurodegenerative Diseases will test United Neuroscience Endobody vaccine candidates using human postmortem tissue samples and preclinical models of neurodegenerative disease.

“We are committed to applying our Endobody technology in areas of great potential impact and working with researchers who are best positioned to accelerate development of therapeutics," stated Mei Mei Hu, chief executive officer of UNS. “It takes a many minds, a team, an ecosystem, to beat a disease as Alzheimer’s. Working with leading researchers as Marc Diamond at The Center for Alzheimer’s and Neurodegenerative Diseases at UT Southwestern will provide important data as we expand our clinical pipeline to include tau protein as a mechanistic target."

繼續閱讀

發表於 公司新聞, 生醫新知, 產業訊息, 社會經濟 | 發表迴響

數字台灣HD200中國的獨角獸與台灣的獨角獸 謝金河 李紹唐 林之晨

發表於 政治觀察, 社會經濟 | 發表迴響

亞馬遜打開生死戰 阿里巴巴、Google地位將不保!? – 關鍵時刻精選 黃世聰 朱學恒

發表於 社會經濟 | 發表迴響